Effect of repeated administration of 4-methylpyrazole on renal function and lipid peroxidation products in rat kidney after ethylene glycol poisoning

被引:1
作者
Sommerfeld-Klatta, Karina [1 ]
Przystanowicz, Jedrzej [1 ]
Kowalowka-Zawieja, Joanna [1 ]
Zielinska-Psuja, Barbara [1 ]
机构
[1] Poznan Univ Med Sci, Dept Toxicol, Poznan, Poland
关键词
4-Methylpyrazole; Ethylene glycol; Kidney; Oxidative stress; SPRAGUE-DAWLEY RATS; CLINICAL TOXICOLOGY; ETHANOL TREATMENT; OXIDATIVE STRESS; FOMEPIZOLE; KINETICS; PHARMACOKINETICS; FORMALDEHYDE; DISPOSITION; METABOLITE;
D O I
10.1016/j.etap.2017.10.004
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Toxic effects of ethylene glycol (EG) and its metabolites are mainly related to metabolic acidosis and kidney damage. EG biotransformation involving CYP2E1 affects the oxidant-antioxidant balance. The study assessed the effect of repeated administration of 4-methylpyrazole (4MP, 15 mg/kg b.w. after 2 h, followed by 10 mg/kg b.w. every 12 h) on renal function (creatinine, urea and urinary protein levels) as well as products of kidney's lipid peroxidation (MDA and TBARS levels) in rats poisoned with EG (5745 mg/kg b.w.). Serum EG and glycolic acid (GA) concentrations were measured throughout the experiment. Repeated administration of 4MP reduced the rate of EG elimination, extended the period of EG persistence in serum and significantly limited formation of GA. The study showed the temporary intensification of kidney oxidative processes that correlated with changes in kidney function. It was found that the use of 4MP in EG poisoning inhibited its biotransformation to toxic metabolites, but simultaneously intensified oxidative damages in kidneys.
引用
收藏
页码:290 / 296
页数:7
相关论文
共 47 条
  • [1] ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43
  • [2] Armstrong D, 1998, Methods Mol Biol, V108, P315
  • [3] Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P537
  • [4] Battistella M, 2002, ANN PHARMACOTHER, V36, P1085
  • [5] Fomepizole for the treatment of ethylene glycol poisoning
    Brent, J
    McMartin, K
    Phillips, S
    Burkhart, KK
    Donovan, JW
    Wells, M
    Kulig, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (11) : 832 - 838
  • [6] Current management of ethylene glycol poisoning
    Brent, J
    [J]. DRUGS, 2001, 61 (07) : 979 - 988
  • [7] 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report
    Bronstein, Alvin C.
    Spyker, Daniel A.
    Cantilena, Louis R., Jr.
    Green, Jody L.
    Rumack, Barry H.
    Giffin, Sandra L.
    [J]. CLINICAL TOXICOLOGY, 2010, 48 (10) : 979 - 1178
  • [8] Ethylene glycol exposure: an evidence-based consensus guideline for out-of-hospital management
    Caravati, EM
    Erdman, AR
    Christianson, G
    Manoguerra, AS
    Booze, LL
    Woolf, AD
    Olson, KR
    Chyka, PA
    Scharman, EJ
    Wax, PM
    Keyes, DC
    Troutman, WG
    [J]. CLINICAL TOXICOLOGY, 2005, 43 (05) : 327 - 345
  • [9] AN INTEGRATED PERSPECTIVE ON THE DEVELOPMENTAL TOXICITY OF ETHYLENE-GLYCOL
    CARNEY, EW
    [J]. REPRODUCTIVE TOXICOLOGY, 1994, 8 (02) : 99 - 113
  • [10] Effects of subacute treatment of ethylene glycol on serum marker enzymes and erythrocyte and tissue antioxidant defense systems and lipid peroxidation in rats
    Celik, Ismail
    Suzek, Huseyin
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2007, 167 (02) : 145 - 152